BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15459215)

  • 41. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
    Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
    Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unique MRI findings as an early predictor of osteonecrosis in pediatric acute lymphoblastic leukemia.
    Sansgiri RK; Neel MD; Soto-Fourier M; Kaste SC
    AJR Am J Roentgenol; 2012 May; 198(5):W432-9. PubMed ID: 22528924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.
    Dawidowska M; Kosmalska M; Sędek Ł; Szczepankiewicz A; Twardoch M; Sonsala A; Szarzyńska-Zawadzka B; Derwich K; Lejman M; Pawelec K; Obitko-Płudowska A; Pawińska-Wąsikowska K; Kwiecińska K; Kołtan A; Dyla A; Grzeszczak W; Kowalczyk JR; Szczepański T; Ziętkiewicz E; Witt M
    Sci Rep; 2016 Jul; 6():29427. PubMed ID: 27427275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
    Bürger B; Beier R; Zimmermann M; Beck JD; Reiter A; Schrappe M
    Pediatr Blood Cancer; 2005 Mar; 44(3):220-5. PubMed ID: 15514916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Asian population may have a lower incidence of hip osteonecrosis in childhood acute lymphoblastic leukemia.
    Arakawa Y; Masutani S; Oshima K; Mitani Y; Mori M; Fukuoka K; Moriwaki K; Kato M; Taira K; Tanami Y; Nakazawa A; Koh K
    Int J Hematol; 2021 Aug; 114(2):271-279. PubMed ID: 34008044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Skeletal-related side effects of acute lymphoblastic leukemia treatment in children].
    Beniczky NJ; Hosszú É; Erdélyi DJ; Müller J; Jakab Z; Kovács G
    Orv Hetil; 2020 Dec; 161(49):2086-2093. PubMed ID: 33279884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Bond J; Adams S; Richards S; Vora A; Mitchell C; Goulden N
    Blood; 2011 Sep; 118(9):2632-3. PubMed ID: 21885611
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
    Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass.
    Zajícková K; Zofková I; Bahbouh R; Krepelová A
    Physiol Res; 2002; 51(5):501-9. PubMed ID: 12470203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.
    te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Uitterlinden AG; Hop WC; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2010 May; 95(5):752-9. PubMed ID: 20015871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
    Ojala AE; Lanning FP; Pääkkö E; Lanning BM
    Med Pediatr Oncol; 1997 Oct; 29(4):260-5. PubMed ID: 9251731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia.
    van Beek RD; Bezemer DD; Meijerink JP; de Muinck Keizer-Schrama SM; Haas OA; Te Winkel L; Pieters R; van den Heuvel-Eibrink M
    Leukemia; 2006 May; 20(5):879-80. PubMed ID: 16525499
    [No Abstract]   [Full Text] [Related]  

  • 54. Team approach: Management of osteonecrosis in children with acute lymphoblastic leukemia.
    Jones LC; Kaste SC; Karol SE; DeFeo B; Kim HKW; Neel MD; Levin AS
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28509. PubMed ID: 32860663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetics of pleiotropic effects of dexamethasone.
    Ramsey LB; Pounds S; Cheng C; Cao X; Yang W; Smith C; Karol SE; Liu C; Panetta JC; Inaba H; Rubnitz JE; Metzger ML; Ribeiro RC; Sandlund JT; Jeha S; Pui CH; Evans WE; Relling MV
    Pharmacogenet Genomics; 2017 Aug; 27(8):294-302. PubMed ID: 28628558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia].
    Engelbrecht V; Scherer A; Bruder M; Körholz D; Mödder U
    Rofo; 2000 Apr; 172(4):336-41. PubMed ID: 10961217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
    Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
    Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population.
    Nazki FH; Masood A; Banday MA; Bhat A; Ganai BA
    Genet Mol Res; 2012 Apr; 11(2):906-17. PubMed ID: 22576918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
    Toksvang LN; Andrés-Jensen L; Rank CU; Niinimäki R; Nersting J; Nielsen SN; Mogensen SS; Harila-Saari A; Abrahamsson J; Joelsson J; Overgaard UM; Quist-Paulsen P; Griškevičius L; Jónsson ÓG; Vaitkevičienė G; Frandsen TL; Toft N; Grell K; Schmiegelow K
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):911-917. PubMed ID: 34145469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MR imaging of osteonecrosis of the knee in children with acute lymphocytic leukemia.
    Karimova EJ; Kaste SC
    Pediatr Radiol; 2007 Nov; 37(11):1140-6. PubMed ID: 17768614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.